New vistas in the diagnosis of diabetic polyneuropathy

Endocrine

Volumn 47, Issue 3, 2014, Pages 690-698

  Papanas, Nikolaos ^a   Ziegler, Dan ^a,b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Devices; Diabetes mellitus; Diabetic polyneuropathy; Diagnosis; Screening

Indexed keywords

CONFOCAL MICROSCOPY; CORNEAL CONFOCAL MICROSCOPY; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; HUMAN; POINT OF CARE TESTING; PREDICTIVE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; STEEL BALL BEARING; TACTILE CIRCUMFERENTIAL DISCRIMINATOR; VALIDATION STUDY; DIABETIC NEUROPATHIES; EARLY DIAGNOSIS; PATHOPHYSIOLOGY;

DIABETIC NEUROPATHIES; EARLY DIAGNOSIS; HUMANS;

EID: 84911962778     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0285-z     Document Type: Review

References (71)

1. A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, R. Freeman, R.A. Malik, R.E. Maser, J.M. Sosenko, D. Ziegler, American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956–962 (2005)
2. S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R.A. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293 (2010)
3. A.L. Carrington, J.E. Shaw, C.H. Van Schie, C.A. Abbott, L. Vileikyte, A.J. Boulton, Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25, 2010–2015 (2002)
4. N. Papanas, E. Maltezos, The diabetic foot: established and emerging treatments. Acta Clin. Belg. 62, 230–238 (2007)
5. A.J. Boulton, The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab. Res. Rev. 24(Suppl 1), S3–S6 (2008)
6. N. Papanas, E. Maltezos, M. Edmonds, Salvation of the diabetic foot: still a quest for the Holy Grail? Vasa 40, 267–269 (2011)
7. A.J. Boulton, R.S. Kirsner, L. Vileikyte, Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med. 351, 48–55 (2004)
8. J. Apelqvist, Diagnostics and treatment of the diabetic foot. Endocrine 41, 384–397 (2012)
9. N.K. Chammas, R.L. Hill, A.V. Foster, M.E. Edmonds, Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionate model. J. Int. Med. Res. 30, 553–559 (2002)
10. J. van Baal, R. Hubbard, F. Game, W. Jeffcoate, Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 33, 1086–1089 (2010)
11. N. Papanas, A.I. Vinik, D. Ziegler, Neuropathy in prediabetes: does the clock start ticking early? Nat. Rev. Endocrinol. 7, 682–690 (2011)
12. N. Papanas, D. Ziegler, Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology 59, 193–198 (2013)
13. N. Papanas, D. Ziegler, New diagnostic tests for diabetic distal symmetric polyneuropathy. J. Diabetes Complic. 25, 44–51 (2011)
14. N. Papanas, A.J. Boulton, R.A. Malik, C. Manes, O. Schnell, V. Spallone, N. Tentolouris, S. Tesfaye, P. Valensi, D. Ziegler, P. Kempler, A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet. Med. 30, 525–534 (2013)
15. D. Ziegler, E. Siekierka-Kleiser, B. Meyer, M. Schweers, Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care 28, 1169–1174 (2005)
16. G. Rayman, P.R. Vas, N. Baker, C.G. Taylor Jr, C. Gooday, A.I. Alder, M. Donohoe, The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 34, 1517–1518 (2011)
17. F.L. Bowling, C.A. Abbott, W.E. Harris, S. Atanasov, R.A. Malik, A.J. Boulton, A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet. Med. 29, 1550–1552 (2012)
18. N. Bracewell, F. Game, W. Jeffcoate, B.E. Scammell, Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes. Diabet. Med. 29, 1553–1555 (2012)
19. A.I. Vinik, X. Kong, J.T. Megerian, S.N. Gozani, Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol. Ther. 8, 654–662 (2006)
20. L. Vileikyte, G. Hutchings, S. Hollis, A.J. Boulton, The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 20, 623–626 (1997)
21. N. Papanas, A. Gries, E. Maltezos, R. Zick, The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot. Diabetologia 49, 739–743 (2006)
22. J.H. Calvet, J. Dupin, H. Winiecki, P.E. Schwarz, Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp. Clin. Endocrinol. Diabetes 121, 80–83 (2013)
23. G. Lauria, M. Bakkers, C. Schmitz, R. Lombardi, P. Penza, G. Devigili, A.G. Smith, S.T. Hsieh, S.I. Mellgren, T. Umapathi, D. Ziegler, C.G. Faber, I.S. Merkies, Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher. Nerv. Syst. 15, 202–207 (2010)
24. N. Papanas, D. Ziegler, Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr. Diab. Rep. 13, 488–499 (2013)
25. ®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 113, 195–198 (2005)
26. N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes. Diabetes Educ. 33, 257–266 (2007)
27. V. Spallone, R. Morganti, M. Siampli, T. Fedele, C. D’Amato, L. Cacciotti, M.R. Maiello, Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet. Med. 26, 686–692 (2009)
28. N. Papanas, P. Paschos, D. Papazoglou, K. Papatheodorou, K. Paletas, E. Maltezos, A. Tsapas, Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. Diabetes Care 34, 1378–1382 (2011)
29. N. Papanas, G. Giassakis, K. Papatheodorou, D. Papazoglou, C. Monastiriotis, D. Christakidis, H. Piperidou, E. Maltezos, Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 115, 58–61 (2007)
30. D. Ziegler, N. Papanas, M. Roden, for the GDC Study Group, Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet. Med. 28, 1412–1415 (2011)
31. C. Manes, N. Papanas, T. Exiara, N. Katsiki, S. Papantoniou, E. Kirlaki, S. Tsotoulidis, N. Kefalogiannis, E. Maltezos, The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study. Exp. Clin. Endocrinol. Diabetes 122, 195–199 (2014)
32. A. Tsapas, A. Liakos, P. Paschos, T. Karagiannis, E. Bekiari, N. Tentolouris, P. Boura, A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis. Metabolism 63, 584–592 (2014)
33. N. Tentolouris, V. Achtsidis, K. Marinou, N. Katsilambros, Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31, 236–237 (2008)
34. N. Papanas, K. Papatheodorou, D. Papazoglou, S. Kotsiou, E. Maltezos, A prospective study on the use of the indicator test Neuropad for the early diagnosis of peripheral neuropathy in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119, 122–125 (2011)
35. N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp. Clin. Endocrinol. Diabetes 113, 577–581 (2005)
36. D. Ziegler, N. Papanas, W. Rathmann, M. Heier, M. Scheer, C. Meisinger, KORA Study Group. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey. Diabetes Metab. Res. Rev. 28, 692–697 (2012)
37. M.J. Young, A.J. Boulton, A.F. MacLeod, D.R. Williams, P.H. Sonksen, A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36, 150–154 (1993)
38. B.A. Perkins, J. Grewal, E. Ng, M. Ngo, V. Bril, Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care 29, 2023–2027 (2006)
39. A.I. Vinik, M.S. Emley, J.T. Megerian, S.N. Gozani, Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system. Diabetes Technol. Ther. 6, 816–824 (2004)
40. X. Kong, S.N. Gozani, M.T. Hayes, D.H. Weinberg, NC-stat sensory nerve conduction studies in the median and ulnar nerves of symptomatic patients. Clin. Neurophysiol. 117, 405–413 (2006)
41. X. Kong, E.A. Lesser, J.T. Megerian, S.N. Gozani, Repeatability of nerve conduction measurements using automation. J. Clin. Monit. Comput. 20, 405–410 (2006)
42. B. Boettcher, B. Tracey, X. Kong, M. Williams, S.N. Gozani, A rapid, low-cost, point-of-care test for diabetic peripheral neuropathy. Diabetes 60, 637 (2011)
43. X. Kong, B. Boettcher, K. Snow, S. Gozani, Reproducibility of a rapid point-of-care sural nerve conduction test. Diabetes 61, 595 (2012)
44. A.I. Vinik, S.N. Gozani, Loss of sural responses estimated by a rapid and easily administered technique identifies greater neuropathy severity and risk in a general diabetes population. Diabetes 60, 650 (2011)
45. J.A. Lee, E.M. Halpern, L.E. Lovblom, E. Yeung, V. Bril, B.A. Perkins, Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS ONE 9, e86515 (2014)
46. R.E. Maser, C. Laudadio, M.J. Lenhard, G.S. DeCherney, A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes. Diabetes Care 20, 179–181 (1997)
47. H. Gin, R. Baudoin, C.H. Raffaitin, V. Rigalleau, C. Gonzalez, Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab. 37, 527–532 (2011)
48. C.M. Casellini, H.K. Parson, M.S. Richardson, M.L. Nevoret, A.I. Vinik, Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol. Ther. 15, 948–953 (2013)
49. S. Løseth, E. Stålberg, R. Jorde, S.I. Mellgren, Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J. Neurol. 255, 1197–1202 (2008)
50. Joint Task Force of the EFNS and the PNS, European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J. Peripher. Nerv. Syst. 15, 79–92 (2010)
51. M.I. Myers, A.C. Peltier, Uses of skin biopsy for sensory and autonomic nerve assessment. Curr. Neurol. Neurosci. Rep. 13, 323 (2013)
52. C. Quattrini, M. Jeziorska, A.J. Boulton, R.A. Malik, Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31, 140–145 (2008)
53. C. Quattrini, M. Tavakoli, M. Jeziorska, P. Kallinikos, S. Tesfaye, J. Finnigan, A. Marshall, A.J. Boulton, N. Efron, R.A. Malik, Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56, 2148–2154 (2007)
54. H. Narayanaswamy, P. Facer, V.P. Misra, M. Timmers, G. Byttebier, T. Meert, P. Anand, A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J. Clin. Neurosci. 19, 1490–1496 (2012)
55. M. Polydefkis, P. Hauer, S. Sheth, M. Sirdofsky, J.W. Griffin, J.C. McArthur, The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127, 1606–1615 (2004)
56. D. Ziegler, N. Papanas, A. Zhivov, S. Allgeier, K. Winter, I. Ziegler, J. Brüggemann, A. Strom, S. Peschel, B. Köhler, O. Stachs, R. F. Guthoff, M. Roden, for the GDS Group, Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. doi:10.2337/db13-1819
57. A. Strom, J. Brüggemann, I. Ziegler, K. Jeruschke, J. Weiss, H. Al-Hasani, M. Roden, D. Ziegler, for the GDS Group, Pronounced reduction of cutaneous Langerhans cell density in recently diagnosed type 2 diabetes. Diabetes 63, 1148–1153 (2014)
58. B. Köhler, S. Allgeier, F. Eberle, R. Guthoff, S. Maier, O. Stachs, A. Zhivov, D. Ziegler, G. Bretthauer, Image reconstruction of the corneal subbasal nerve plexus with extended field of view from focus image stacks of a confocal laser scanning microscope. Klin. Monbl. Augenheilkd. 228, 1060–1066 (2011)
59. E.A. Sellers, I. Clark, M. Tavakoli, H.J. Dean, J. McGavock, R.A. Malik, The acceptability and feasibility of corneal confocal microscopy to detect early diabetic neuropathy in children: a pilot study. Diabet. Med. 30, 630–631 (2013)
60. C. Quattrini, M. Tavakoli, P. Kallinikos et al., Comparing skin biopsy with corneal confocal microscopy: diagnostic yield of nerve fiber density. Diabetologia 53(Suppl 1), A1114 (2010)
61. M. Tavakoli, C. Quattrini, P. Begum et al., Neuropad and corneal confocal microscopy: new indications for human diabetic neuropathy. Diabetologia 53(Suppl 1), A1112 (2010)
62. F. Ishibashi, R. Kojima, A. Kawasaki, E. Yamanaka, A. Kosaka, H. Uetake, Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus. J. Diabetes Invest. (2013). doi:10.1111/jdi.12171
63. M. Tavakoli, P. Kallinikos, A. Iqbal, A. Herbert, H. Fadavi, N. Efron, A.J. Boulton, R.A. Malik, Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet. Med. 28, 1261–1267 (2011)
64. M. Tavakoli, M. Mitu-Pretorian, I.N. Petropoulos, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M. Jeziorska, A. Marshall, N. Efron, A.J. Boulton, T. Augustine, R.A. Malik, Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 62, 254–260 (2013)
65. N. Efron, K. Edwards, N. Roper, N. Pritchard, G.P. Sampson, A.M. Shahidi, D. Vagenas, A. Russell, J. Graham, M.A. Dabbah, R.A. Malik, Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes. Eye Contact Lens 36, 245–248 (2010)
66. P. Hertz, V. Bril, A. Orszag, A. Ahmed, E. Ng, P. Nwe, M. Ngo, P.A. Perkins, Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet. Med. 28, 1253–1260 (2011)
67. I.N. Petropoulos, T. Manzoor, P. Morgan, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M.A. Dabbah, X. Chen, J. Graham, M. Tavakoli, R.A. Malik, Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea 32, e83–e89 (2013)
68. W.H. Herman, L. Kennedy, Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 28, 1480–1841 (2005)
69. C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41, 89–95 (2012)
70. American Diabetes Association, Standards of medical care in diabetes. Diabetes Care 36(Suppl 1), S11–S66 (2013)
71. R. Sayın, M. Aslan, M. E. Kucukoglu, A. Luleci, M. Atmaca, R. Esen, H. Demir, Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Endocrine. doi:10.1007/s12020-013-0136-3